Pandemic’s mitigation efforts may have contributed to drop in clinical trial completion rates

Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials.